Affected market: Pharmaceutical packaging
On the basis of the information available to it, the OFT has decided
that the completed acquisition of the Risdon Pharma Group by Rexam plc
does not qualify for investigation under the mergers provisions of the
Enterprise Act 2002 , because neither the UK turnover test nor the share
of supply test in section 23 of the Act is met. A relevant merger
situation has, therefore, not been created.
Published 20 October 2003